|Increased risk of common infections in patients with type 1 and type 2 diabetes mellitus|
L Muller, KJ Gorter, E Hak, WL Goudzwaard, FG Schellevis, ...
Clinical infectious diseases 41 (3), 281-288, 2005
|Clinical signs and symptoms predicting influenza infection|
AS Monto, S Gravenstein, M Elliott, M Colopy, J Schweinle
Archives of internal medicine 160 (21), 3243-3247, 2000
|Effectiveness of influenza vaccine in the community-dwelling elderly|
KL Nichol, JD Nordin, DB Nelson, JP Mullooly, E Hak
New England Journal of Medicine 357 (14), 1373-1381, 2007
|Oral decontamination with chlorhexidine reduces the incidence of ventilator-associated pneumonia|
M Koeman, AJAM van der Ven, E Hak, HCA Joore, K Kaasjager, ...
American journal of respiratory and critical care medicine 173 (12), 1348-1355, 2006
|β-blockers may reduce mortality and risk of exacerbations in patients with chronic obstructive pulmonary disease|
FH Rutten, NPA Zuithoff, E Hak, DE Grobbee, AW Hoes
Archives of internal medicine 170 (10), 880-887, 2010
|Influence of high-risk medical conditions on the effectiveness of influenza vaccination among elderly members of 3 large managed-care organizations|
E Hak, J Nordin, F Wei, J Mullooly, S Poblete, R Strikas, KL Nichol
Clinical Infectious Diseases 35 (4), 370-377, 2002
|Evaluation of impermeable covers for bedding in patients with allergic rhinitis|
I Terreehorst, E Hak, AJ Oosting, Z Tempels-Pavlica, JGR de Monchy, ...
New England Journal of Medicine 349 (3), 237-246, 2003
|Clinical effectiveness of influenza vaccination in persons younger than 65 years with high-risk medical conditions: the PRISMA study|
E Hak, E Buskens, GA van Essen, DH de Bakker, DE Grobbee, ...
Archives of internal medicine 165 (3), 274-280, 2005
|Rationale and design of CAPITA: a RCT of 13-valent conjugated pneumococcal vaccine efficacy among older adults|
E Hak, DE Grobbee, EA Sanders, TJ Verheij, M Bolkenbaas, SM Huijts, ...
Neth J Med 66 (9), 378-383, 2008
|Impact of rapid detection of viral and atypical bacterial pathogens by real-time polymerase chain reaction for patients with lower respiratory tract infection|
JJ Oosterheert, AM Van Loon, R Schuurman, AIM Hoepelman, E Hak, ...
Clinical infectious diseases 41 (10), 1438-1444, 2005
|Effects of pneumococcal conjugate vaccine 2 years after its introduction, the Netherlands|
GD Rodenburg, SC de Greeff, AGCS Jansen, HE de Melker, LM Schouls, ...
Emerging infectious diseases 16 (5), 816, 2010
|First cases of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infections in France, investigations and implications for the prevention of human-to-human transmission …|
A Mailles, K Blanckaert, P Chaud, S Van der Werf, B Lina, V Caro, ...
Eurosurveillance 18 (24), 20502, 2013
|Invasive pneumococcal disease among adults: associations among serotypes, disease characteristics, and outcome|
AGSC Jansen, GD Rodenburg, A van der Ende, L van Alphen, ...
Clinical infectious diseases 49 (2), e23-e29, 2009
|Negative attitude of highly educated parents and health care workers towards future vaccinations in the Dutch childhood vaccination program|
E Hak, Y Schönbeck, H De Melker, GA Van Essen, EAM Sanders
Vaccine 23 (24), 3103-3107, 2005
|Effect of reduced-dose schedules with 7-valent pneumococcal conjugate vaccine on nasopharyngeal pneumococcal carriage in children: a randomized controlled trial|
EJM van Gils, RH Veenhoven, E Hak, GD Rodenburg, D Bogaert, ...
Jama 302 (2), 159-167, 2009
|Influenza-and respiratory syncytial virus-associated mortality and hospitalisations|
AGSC Jansen, EAM Sanders, AW Hoes, AM van Loon, E Hak
European Respiratory Journal 30 (6), 1158-1166, 2007
|Confounding by indication in non-experimental evaluation of vaccine effectiveness: the example of prevention of influenza complications|
E Hak, TJM Verheij, DE Grobbee, KL Nichol, AW Hoes
Journal of Epidemiology & Community Health 56 (12), 951-955, 2002
|Statin treatment and reduced risk of pneumonia in patients with diabetes|
EMW van de Garde, E Hak, PC Souverein, AW Hoes, JMM van den Bosch, ...
Thorax 61 (11), 957-961, 2006
|Usefulness of consecutive C-reactive protein measurements in follow-up of severe community-acquired pneumonia|
AHW Bruns, JJ Oosterheert, E Hak, AIM Hoepelman
European Respiratory Journal 32 (3), 726-732, 2008
|Clinical effectiveness of first and repeat influenza vaccination in adult and elderly diabetic patients|
I Looijmans-Van den Akker, TJM Verheij, E Buskens, KL Nichol, ...
Diabetes care 29 (8), 1771-1776, 2006